Ian P. Street
Randwick, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia.
Journal: bioRxiv : the preprint server for biology
Published: December 23, 2024
Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia.
Journal: Cancer discovery
Published: October 22, 2024
The Super Enhancer-Driven Long Noncoding RNA PRKCQ-AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 08, 2024
BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol Biosynthesis.
Journal: International journal of molecular sciences
Published: June 26, 2024
Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
Journal: Cell communication and signaling : CCS
Published: January 15, 2024
BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents.
Journal: Neuropharmacology
Published: January 28, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.
Journal: Cell chemical biology
Published: July 06, 2022
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.
Journal: Cell death & disease
Published: April 02, 2020
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents.
Journal: Journal of medicinal chemistry
Published: March 03, 2020
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 24, 2019
Fragment screening for a protein-protein interaction inhibitor to WDR5.
Journal: Structural dynamics (Melville, N.Y.)
Published: August 02, 2019
Last Updated: 09/26/2026